446 related articles for article (PubMed ID: 11560978)
1. Lung cancer chemoprevention: an integrated approach.
Lippman SM; Spitz MR
J Clin Oncol; 2001 Sep; 19(18 Suppl):74S-82S. PubMed ID: 11560978
[TBL] [Abstract][Full Text] [Related]
2. Nutritional aspects regarding lung cancer chemoprevention.
Thanopoulou E; Baltayiannis N; Lykogianni V
J BUON; 2006; 11(1):7-20. PubMed ID: 17318947
[TBL] [Abstract][Full Text] [Related]
3. Molecularly targeted approaches to the chemoprevention of lung cancer.
Khuri FR; Cohen V
Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4249s-4253s. PubMed ID: 15217968
[TBL] [Abstract][Full Text] [Related]
4. Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia.
Lam S; Xu X; Parker-Klein H; Le Riche JC; Macaulay C; Guillaud M; Coldman A; Gazdar A; Lotan R
Int J Oncol; 2003 Dec; 23(6):1607-13. PubMed ID: 14612933
[TBL] [Abstract][Full Text] [Related]
5. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.
Goodman GE; Thornquist MD; Balmes J; Cullen MR; Meyskens FL; Omenn GS; Valanis B; Williams JH
J Natl Cancer Inst; 2004 Dec; 96(23):1743-50. PubMed ID: 15572756
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine lung carcinogenesis in hamsters is inhibited by green tea or theophylline while the development of adenocarcinomas is promoted: implications for chemoprevention in smokers.
Schuller HM; Porter B; Riechert A; Walker K; Schmoyer R
Lung Cancer; 2004 Jul; 45(1):11-8. PubMed ID: 15196729
[TBL] [Abstract][Full Text] [Related]
7. Risk biomarkers and current strategies for cancer chemoprevention.
Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
[TBL] [Abstract][Full Text] [Related]
8. Role of biology and prevention in aerodigestive tract cancers.
Greenwald P; Stern HR
J Natl Cancer Inst Monogr; 1992; (13):3-14. PubMed ID: 1389693
[TBL] [Abstract][Full Text] [Related]
9. [Chemoprevention of lung cancer. A review about previous studies, results and future developments].
Heckmayr M
Pneumologie; 2004 Jun; 58(6):408-15. PubMed ID: 15216434
[TBL] [Abstract][Full Text] [Related]
10. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
Goodman GE; Schaffer S; Omenn GS; Chen C; King I
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):518-26. PubMed ID: 12814997
[TBL] [Abstract][Full Text] [Related]
11. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers.
Omenn GS; Goodman G; Thornquist M; Grizzle J; Rosenstock L; Barnhart S; Balmes J; Cherniack MG; Cullen MR; Glass A
Cancer Res; 1994 Apr; 54(7 Suppl):2038s-2043s. PubMed ID: 8137335
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future.
Omenn GS
Eur J Cancer Prev; 2007 Jun; 16(3):184-91. PubMed ID: 17415088
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of lung cancer: from concept to reality.
van Zandwijk N
Rocz Akad Med Bialymst; 2003; 48():5-10. PubMed ID: 14737934
[TBL] [Abstract][Full Text] [Related]
14. Progress in lung cancer chemoprevention.
Cohen V; Khuri FR
Cancer Control; 2003; 10(4):315-24. PubMed ID: 12915810
[TBL] [Abstract][Full Text] [Related]
15. Application of molecular epidemiology to lung cancer chemoprevention.
Mooney LA; Perera FP
J Cell Biochem Suppl; 1996; 25():63-8. PubMed ID: 9027600
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of lung cancer.
Buiatti E; Geddes M; Arniani S
Ann Ist Super Sanita; 1996; 32(1):133-44. PubMed ID: 8967716
[TBL] [Abstract][Full Text] [Related]
17. Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer.
Kelloff GJ; Sigman CC; Johnson KM; Boone CW; Greenwald P; Crowell JA; Hawk ET; Doody LA
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):127-37. PubMed ID: 10698472
[TBL] [Abstract][Full Text] [Related]
18. [Chemoprevention perspectives for bronchial cancer].
Scheid P; Vignaud JM; Martinet N; Martinet Y
Rev Pneumol Clin; 2001 Jun; 57(3):193-9. PubMed ID: 11416802
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer: chemoprevention and intermediate effect markers.
Tockman MS
IARC Sci Publ; 2001; 154():257-70. PubMed ID: 11220665
[TBL] [Abstract][Full Text] [Related]
20. Physical activity in relation to all-site and lung cancer incidence and mortality in current and former smokers.
Alfano CM; Klesges RC; Murray DM; Bowen DJ; McTiernan A; Vander Weg MW; Robinson LA; Cartmel B; Thornquist MD; Barnett M; Goodman GE; Omenn GS
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2233-41. PubMed ID: 15598785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
